chimeric antigen receptor T cell treatment

BIOLOGICAL2 trials

Sponsors

Beijing Boren Hospital

Conditions

Refractory T Lymphoblastic Leukemia/LymphomaRelapse/RecurrenceT Cell LymphomaT-cell LeukemiaT-cell Leukemia/Lymphoma

Phase 1

Phase I Clinical Trial of Autologous CD7-CAR T Cell Therapy for High-risk Acute T-cell Leukemia/lymphoma

CompletedNCT04840875

Beijing Boren HospitalT-cell Leukemia, T Cell Lymphoma

Start: 2021-09-14End: 2023-09-01Updated: 2024-11-14

Phase 2

Multi-centers, Open-Label, Phase 2 Study to Evaluate the Efficacy and Safety of Donor-Derived CD7 CAR T Cells in Subjects With Relapsed or Refractory T-cell Leukemia/Lymphoma

CompletedNCT04689659

Beijing Boren HospitalRefractory T Lymphoblastic Leukemia/Lymphoma, Relapse/Recurrence, T-cell Leukemia/Lymphoma

Start: 2021-12-01End: 2024-04-03Updated: 2025-05-18

Related Papers

Donor-derived CD7 CAR T cells for pediatric and adult relapsed/refractory T-ALL/LBL: a phase 2 trial.

2025-12-011 citations

Potential benefits of using a different donor for transplantation consolidation after donor-derived CD7 CAR T.

Journal of Clinical Oncology2025-05-28

CD7 CAR T-Cell Therapy in Relapsed or Refractory T-Cell Acute Lymphoblastic Leukemia: A Retrospective Study

Blood2024-11-052 citations

Autologous CD7 CAR-T cells generated without T cell pre-selection in pediatric patients with relapsed/refractory T-ALL: A phase I trial.

2024-09-077 citations

CAR T-Cell Therapy in Relapsed or Refractory T-Cell Acute Lymphoblastic Leukemia/Lymphoma: A Retrospective Study

Blood2023-11-022 citations

Efficacy and Safety of Donor-Derived CD7 CAR T Cells for r/r T-Cell Acute Lymphoblastic Leukemia/Lymphoma: Interim Analysis from a Phase 2 Trial

Blood2022-11-157 citations

Autologous CD7-targeted CAR T-cell therapy for refractory or relapsed T-cell acute lymphoblastic leukemia/lymphoma.

Journal of Clinical Oncology2022-06-0113 citations

Donor-Derived CD7 Chimeric Antigen Receptor T Cells for T-Cell Acute Lymphoblastic Leukemia: First-in-Human, Phase I Trial

Journal of Clinical Oncology2021-07-29279 citations